Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension.

× No keyword cloud information.

11 in total

1. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall.

Authors: H Okunishi; M Miyazaki; T Okamura; N Toda
Journal: Biochem Biophys Res Commun Date: 1987-12-31 Impact factor: 3.575

2. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.

Authors: E Nunez; K Hosoya; D Susic; E D Frohlich
Journal: Hypertension Date: 1997-01 Impact factor: 10.190

Review 3. Angiotensin receptors and their antagonists.

Authors: T L Goodfriend; M E Elliott; K J Catt
Journal: N Engl J Med Date: 1996-06-20 Impact factor: 91.245

4. Long-term enalapril--a new converting enzyme inhibitor--in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analyzing data.

Authors: J N Lessem; E Rucinska; F F Vickers; J Espie; J A Sromovsky
Journal: Clin Exp Hypertens A Date: 1985

5. Angiotensin II-forming pathways in normal and failing human hearts.

Authors: H Urata; B Healy; R W Stewart; F M Bumpus; A Husain
Journal: Circ Res Date: 1990-04 Impact factor: 17.367

6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.

Authors: M Azizi; G Chatellier; T T Guyene; D Murieta-Geoffroy; J Ménard
Journal: Circulation Date: 1995-08-15 Impact factor: 29.690

7. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.

Authors: Y A Ding; S M Chang; T C Chou
Journal: J Hum Hypertens Date: 1995-08 Impact factor: 3.012

8. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

Authors: A H van den Meiracker; A J Man in 't Veld; P J Admiraal; H J Ritsema van Eck; F Boomsma; F H Derkx; M A Schalekamp
Journal: J Hypertens Date: 1992-08 Impact factor: 4.844

Review 9. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.

Authors: Y Liao; A Husain
Journal: Can J Cardiol Date: 1995-08 Impact factor: 5.223

10. Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.

Authors: L S Zisman; W T Abraham; G E Meixell; B N Vamvakias; R A Quaife; B D Lowes; R L Roden; S J Peacock; B M Groves; M V Raynolds
Journal: J Clin Invest Date: 1995-09 Impact factor: 14.808

5 in total

1. The renin-angiotensin system antagonism in the treatment of hypertension.

Authors: J D Bisognano; R J Cody
Journal: Curr Hypertens Rep Date: 1999-08 Impact factor: 5.369

Review 2. Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.

Authors: W J Elliott
Journal: Curr Hypertens Rep Date: 2000-08 Impact factor: 5.369

Review 3. Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations.

Authors: Domenic A Sica
Journal: J Clin Hypertens (Greenwich) Date: 2007-01 Impact factor: 3.738

Review 4. Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice.

Authors: Domenic A Sica
Journal: J Clin Hypertens (Greenwich) Date: 2003 Nov-Dec Impact factor: 3.738

Review 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in combination: theory and practice.

Authors: D A Sica; W J Elliott
Journal: J Clin Hypertens (Greenwich) Date: 2001 Nov-Dec Impact factor: 3.738

5 in total